EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy

Iris Garrido-Cano iD, Anna Adam-Artigues, Ana Lameirinhas, Juan F Blandez, Vicente Candela-Noguera, Ana Lluch, Begoña Bermejo, Felix Sancenón iD, Juan Miguel Cejalvo, Ramón Martínez-Máñez iD, Pilar Eroles

ACS Applied Materials & Interfaces · 2023

DOI: 10.1021/acsami.3c07541 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2023. Written by Iris Garrido-Cano and 10 co-authors. Institution: Biomedical Research Institute INCLIVA, Valencia 46010, Spain. Major MEDLINE topics: MicroRNAs, Lung Neoplasms, Nanoparticles. Cited 44 times so far (Crossref); 67 references. The full text is freely available (open access, CC BY 4.0). Funded by: Generalitat Valenciana, European Commission, Ministerio de Ciencia e Innovación.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Despite advances in breast cancer treatment, it remains the leading cause of cancer-related death in women worldwide. In this context, microRNAs have emerged as potential therapeutic targets but still present some limitations for in vivo applications. Particularly, miR-200c-3p is a well-known tumor suppressor microRNA that inhibits tumor progression and metastasis in breast cancer through downregulating ZEB1 and ZEB2. Based on the above, we describe the design and validation of a nanodevice using mesoporous silica nanoparticles for miR-200c-3p delivery for breast cancer treatment. We demonstrate the biocompatibility of the synthesized nanodevices as well as their ability to escape from endosomes/lysosomes and inhibit tumorigenesis, invasion, migration, and proliferation of tumor cells in vitro. Moreover, tumor targeting and effective delivery of miR-200c-3p from the nanoparticles in vivo are confirmed in an orthotopic breast cancer mouse model, and the therapeutic efficacy is also evidenced by a decrease in tumor size and lung metastasis, while showing no signs of toxicity. Overall, our results provide evidence that miR-200c-3p-loaded nanoparticles are a potential strategy for breast cancer therapy and a safe and effective system for tumor-targeted delivery of microRNAs.

Subjects

MeSH terms (MEDLINE)

MicroRNAsLung NeoplasmsNanoparticlesFemaleMiceAnimalsSilicon DioxideCell Line, TumorGene Expression Regulation, NeoplasticCell MovementCell Proliferation

Author keywords

breast cancermesoporous silica nanoparticlesmicroRNAtargeted deliverytherapy

Substances

Silicon DioxideMicroRNAs

Authors and institutions

  • Biomedical Research Institute INCLIVA, Valencia 46010, Spain.
  • Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Valencia 46010, Spain.
  • CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid 28029, Spain.
  • Unidad Mixta de Investigación en Nanomedicina y Sensores, Universitat Politècnica de València, IIS La Fe, Valencia 46026, Spain.
  • Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain.
  • Universitat de València, Valencia 46010, Spain.

ORCID profiles: Iris Garrido-Cano, Felix Sancenón, Ramón Martínez-Máñez

Funding

  • Generalitat Valenciana
  • European Commission
  • Ministerio de Ciencia e Innovación
  • Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina
  • European Regional Development Fund
  • Ministerio de Economía y Competitividad
  • Fundación Científica Asociación Española Contra el Cáncer
  • Sociedad Española de Oncología Médica

Cite

APA

Garrido-Cano, I., Adam-Artigues, A., Lameirinhas, A., Blandez, J. F., Candela-Noguera, V., Lluch, A., Bermejo, B., Sancenón, F., Cejalvo, J. M., Martínez-Máñez, R., & Eroles, P. (2023). Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c07541

Vancouver

Garrido-Cano I, Adam-Artigues A, Lameirinhas A, Blandez JF, Candela-Noguera V, Lluch A, et al. Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c07541

BibTeX
@article{GarridoCano2023,
  author = {Garrido-Cano, Iris and Adam-Artigues, Anna and Lameirinhas, Ana and Blandez, Juan F and Candela-Noguera, Vicente and Lluch, Ana and Bermejo, Begoña and Sancenón, Felix and Cejalvo, Juan Miguel and Martínez-Máñez, Ramón and Eroles, Pilar},
  title = {Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2023},
  doi = {10.1021/acsami.3c07541}
}
Start for free →